Publication: 3906

Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor–Positive, HER2-Positive Breast Cancer
      QxMD      Google Scholar   
Citation:
J Natl Compr Canc Netw vol 22 (7) 463-8
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
14
Parents:
3266   3389   3553  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U24 CA196171, UG1CA232760; U10CA180868, UG1CA189867, U10CA180822, U24CA196067 (NRG Oncology)  
Corr. Author:
 
Authors:
                         
Networks:
LAPS-MN026, NY021, PR028   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N9831, NSABP B-31
Phases:
3
Keywords: